 | • レポートコード：MRC2102QY0799 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、140ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の抗毒素市場について種類別（多価抗毒、一価抗毒）、用途別（非営利団体、病院、診療所）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・抗毒素市場の概要 ・世界の主要地域別抗毒素市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の抗毒素市場規模2015-2026：種類別（多価抗毒、一価抗毒） ・世界の抗毒素市場規模2015-2026：用途別（非営利団体、病院、診療所） ・抗毒素の米国市場規模2015-2020 ・抗毒素のヨーロッパ市場規模2015-2020 ・抗毒素の中国市場規模2015-2020 ・抗毒素の日本市場規模2015-2020 ・抗毒素の東南アジア市場規模2015-2020 ・抗毒素のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・抗毒素の製造コスト分析 ・販売チャネル、流通業者、顧客 ・抗毒素の市場動向・機会・課題 ・調査の結論 |
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings.
CSL is the world leading manufacturer in global Anti-Venom market with the market share of 27%, in terms of revenue, followed by Merck, BTG, Pfizer, Haffkine Bio-Pharmaceutical, Rare Disease Therapeutics, Flynn Pharma, Vins Bioproducts, Bharat Serums and Vaccines, Serum Biotech and MicroPharm. These 11 companies accounted for 68% of the revenue market share in 2019. Asia-Pacific, Middle East and Africa are the largest consumption regions, occupied about 77% of market share, in terms of volume. The application of Anti-Venom in hospital and clinics take the main global shares. The polyvalent Anti-Venom takes more global revenue shares compared to the Monovalent Anti-Venom, which accounts for 67% in 2019.
Market Analysis and Insights: Global Anti-Venom Market
The global Anti-Venom market size is projected to reach US$ 1178.3 million by 2026, from US$ 922.1 million in 2020, at a CAGR of 4.2% during 2021-2026.
Global Anti-Venom Scope and Market Size
The global Anti-Venom market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Venom market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-Venom market is segmented into
Polyvalent Anti-Venom
Monovalent Anti-Venom
Segment by Application, the Anti-Venom market is segmented into
Non-profit Institutions
Hospitals and Clinic
The Anti-Venom market is analysed and market size information is provided by regions (countries). Segment by Application, the Anti-Venom market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-Venom Market Share Analysis
Anti-Venom market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Venom business, the date to enter into the Anti-Venom market, Anti-Venom product introduction, recent developments, etc.
The major vendors covered:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
1 Anti-Venom Market Overview
1.1 Anti-Venom Product Scope
1.2 Anti-Venom Segment by Type
1.2.1 Global Anti-Venom Sales by Type (2020-2026)
1.2.2 Polyvalent Anti-Venom
1.2.3 Monovalent Anti-Venom
1.3 Anti-Venom Segment by Application
1.3.1 Global Anti-Venom Sales Comparison by Application (2020-2026)
1.3.2 Non-profit Institutions
1.3.3 Hospitals and Clinic
1.4 Anti-Venom Market Estimates and Forecasts (2015-2026)
1.4.1 Global Anti-Venom Sales Growth Rate (2015-2026)
1.4.2 Global Anti-Venom Revenue and Growth Rate (2015-2026)
1.4.3 Global Anti-Venom Price Trends (2015-2026)
2 Anti-Venom Estimate and Forecast by Region
2.1 Global Anti-Venom Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Anti-Venom Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Anti-Venom Sales Market Share by Region (2015-2020)
2.2.2 Global Anti-Venom Revenue Market Share by Region (2015-2020)
2.3 Global Anti-Venom Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Anti-Venom Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Anti-Venom Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Anti-Venom Estimates and Projections (2015-2026)
2.4.2 Europe Anti-Venom Estimates and Projections (2015-2026)
2.4.3 China Anti-Venom Estimates and Projections (2015-2026)
2.4.4 Japan Anti-Venom Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Anti-Venom Estimates and Projections (2015-2026)
2.4.6 India Anti-Venom Estimates and Projections (2015-2026)
3 Global Anti-Venom Competition Landscape by Players
3.1 Global Top Anti-Venom Players by Sales (2015-2020)
3.2 Global Top Anti-Venom Players by Revenue (2015-2020)
3.3 Global Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Venom as of 2019)
3.4 Global Anti-Venom Average Price by Company (2015-2020)
3.5 Manufacturers Anti-Venom Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Anti-Venom Players (Opinion Leaders)
4 Global Anti-Venom Market Size by Type
4.1 Global Anti-Venom Historic Market Review by Type (2015-2020)
4.1.1 Global Anti-Venom Sales Market Share by Type (2015-2020)
4.1.2 Global Anti-Venom Revenue Market Share by Type (2015-2020)
4.1.3 Global Anti-Venom Price by Type (2015-2020)
4.2 Global Anti-Venom Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Anti-Venom Sales Forecast by Type (2021-2026)
4.2.2 Global Anti-Venom Revenue Forecast by Type (2021-2026)
4.2.3 Global Anti-Venom Price Forecast by Type (2021-2026)
5 Global Anti-Venom Market Size by Application
5.1 Global Anti-Venom Historic Market Review by Application (2015-2020)
5.1.1 Global Anti-Venom Sales Market Share by Application (2015-2020)
5.1.2 Global Anti-Venom Revenue Market Share by Application (2015-2020)
5.1.3 Global Anti-Venom Price by Application (2015-2020)
5.2 Global Anti-Venom Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Anti-Venom Sales Forecast by Application (2021-2026)
5.2.2 Global Anti-Venom Revenue Forecast by Application (2021-2026)
5.2.3 Global Anti-Venom Price Forecast by Application (2021-2026)
6 United States Anti-Venom Market Facts & Figures
6.1 United States Anti-Venom Sales Market Share by Company (2015-2020)
6.2 United States Anti-Venom Sales Market Share by Type (2015-2020)
6.3 United States Anti-Venom Sales Market Share by Application (2015-2020)
7 Europe Anti-Venom Market Facts & Figures
7.1 Europe Anti-Venom Sales Market Share by Company (2015-2020)
7.2 Europe Anti-Venom Sales Market Share by Type (2015-2020)
7.3 Europe Anti-Venom Sales Market Share by Application (2015-2020)
8 China Anti-Venom Market Facts & Figures
8.1 China Anti-Venom Sales Market Share by Company (2015-2020)
8.2 China Anti-Venom Sales Market Share by Type (2015-2020)
8.3 China Anti-Venom Sales Market Share by Application (2015-2020)
9 Japan Anti-Venom Market Facts & Figures
9.1 Japan Anti-Venom Sales Market Share by Company (3015-3030)
9.2 Japan Anti-Venom Sales Market Share by Type (2015-2020)
9.3 Japan Anti-Venom Sales Market Share by Application (2015-2020)
10 Southeast Asia Anti-Venom Market Facts & Figures
10.1 Southeast Asia Anti-Venom Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Anti-Venom Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Anti-Venom Sales Market Share by Application (2015-2020)
11 India Anti-Venom Market Facts & Figures
11.1 India Anti-Venom Sales Market Share by Company (2015-2020)
11.2 India Anti-Venom Sales Market Share by Type (2015-2020)
11.3 India Anti-Venom Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Anti-Venom Business
12.1 CSL
12.1.1 CSL Corporation Information
12.1.2 CSL Business Overview
12.1.3 CSL Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.1.4 CSL Anti-Venom Products Offered
12.1.5 CSL Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Business Overview
12.2.3 Merck Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Anti-Venom Products Offered
12.2.5 Merck Recent Development
12.3 BTG
12.3.1 BTG Corporation Information
12.3.2 BTG Business Overview
12.3.3 BTG Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.3.4 BTG Anti-Venom Products Offered
12.3.5 BTG Recent Development
12.4 Pfizer
12.4.1 Pfizer Corporation Information
12.4.2 Pfizer Business Overview
12.4.3 Pfizer Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Pfizer Anti-Venom Products Offered
12.4.5 Pfizer Recent Development
12.5 Haffkine Bio-Pharmaceutical
12.5.1 Haffkine Bio-Pharmaceutical Corporation Information
12.5.2 Haffkine Bio-Pharmaceutical Business Overview
12.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Products Offered
12.5.5 Haffkine Bio-Pharmaceutical Recent Development
12.6 Rare Disease Therapeutics
12.6.1 Rare Disease Therapeutics Corporation Information
12.6.2 Rare Disease Therapeutics Business Overview
12.6.3 Rare Disease Therapeutics Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Rare Disease Therapeutics Anti-Venom Products Offered
12.6.5 Rare Disease Therapeutics Recent Development
12.7 Flynn Pharma
12.7.1 Flynn Pharma Corporation Information
12.7.2 Flynn Pharma Business Overview
12.7.3 Flynn Pharma Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Flynn Pharma Anti-Venom Products Offered
12.7.5 Flynn Pharma Recent Development
12.8 Vins Bioproducts
12.8.1 Vins Bioproducts Corporation Information
12.8.2 Vins Bioproducts Business Overview
12.8.3 Vins Bioproducts Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Vins Bioproducts Anti-Venom Products Offered
12.8.5 Vins Bioproducts Recent Development
12.9 Bharat Serums and Vaccines
12.9.1 Bharat Serums and Vaccines Corporation Information
12.9.2 Bharat Serums and Vaccines Business Overview
12.9.3 Bharat Serums and Vaccines Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bharat Serums and Vaccines Anti-Venom Products Offered
12.9.5 Bharat Serums and Vaccines Recent Development
12.10 Serum Biotech
12.10.1 Serum Biotech Corporation Information
12.10.2 Serum Biotech Business Overview
12.10.3 Serum Biotech Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Serum Biotech Anti-Venom Products Offered
12.10.5 Serum Biotech Recent Development
12.11 MicroPharm
12.11.1 MicroPharm Corporation Information
12.11.2 MicroPharm Business Overview
12.11.3 MicroPharm Anti-Venom Sales, Revenue and Gross Margin (2015-2020)
12.11.4 MicroPharm Anti-Venom Products Offered
12.11.5 MicroPharm Recent Development
13 Anti-Venom Manufacturing Cost Analysis
13.1 Anti-Venom Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Anti-Venom
13.4 Anti-Venom Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Anti-Venom Distributors List
14.3 Anti-Venom Customers
15 Market Dynamics
15.1 Anti-Venom Market Trends
15.2 Anti-Venom Opportunities and Drivers
15.3 Anti-Venom Market Challenges
15.4 Anti-Venom Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Anti-Venom Sales (K Vials) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Anti-Venom Sales (K Vials) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Anti-Venom Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Anti-Venom Sales (K Vials) by Region (2015-2020)
Table 5. Global Anti-Venom Sales Market Share by Region (2015-2020)
Table 6. Global Anti-Venom Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Anti-Venom Revenue Share by Region (2015-2020)
Table 8. Global Anti-Venom Sales (K Vials) Forecast by Region (2021-2026)
Table 9. Global Anti-Venom Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Anti-Venom Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Anti-Venom Revenue Share Forecast by Region (2021-2026)
Table 12. Global Anti-Venom (K Vials) of Key Companies (2015-2020)
Table 13. Global Anti-Venom Sales Share by Company (2015-2020)
Table 14. Global Anti-Venom Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Anti-Venom Revenue Share by Company (2015-2020)
Table 16. Global Anti-Venom by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Venom as of 2019)
Table 17. Global Anti-Venom Average Price (USD/Vial) of Key Company (2015-2020)
Table 18. Manufacturers Anti-Venom Manufacturing Sites and Area Served
Table 19. Manufacturers Anti-Venom Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Anti-Venom Players
Table 22. Global Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 23. Global Anti-Venom Sales Share by Type (2015-2020)
Table 24. Global Anti-Venom Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Anti-Venom Price (K Vials) by Type (2015-2020)
Table 26. Global Anti-Venom Sales Share by Type (2021-2026)
Table 27. Global Anti-Venom Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Anti-Venom Revenue Share by Type (2021-2026)
Table 29. Global Anti-Venom Price (K Vials) by Type (2021-2026)
Table 30. Global Anti-Venom Sales (K Vials) by Application (2015-2020)
Table 31. Global Anti-Venom Sales Share by Application (2015-2020)
Table 32. Global Anti-Venom Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Anti-Venom Price (K Vials) by Application (2015-2020)
Table 34. Global Anti-Venom Sales (K Vials) by Application (2021-2026)
Table 35. Global Anti-Venom Sales Share by Application (2021-2026)
Table 36. Global Anti-Venom Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Anti-Venom Revenue Share by Application (2021-2026)
Table 38. Global Anti-Venom Price (K Vials) by Application (2021-2026)
Table 39. United States Anti-Venom Sales (K Vials) by Company (2015-2020)
Table 40. United States Anti-Venom Sales Market Share by Company (2015-2020)
Table 41. United States Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 42. United States Anti-Venom Sales Market Share by Type (2015-2020)
Table 43. United States Anti-Venom Sales (K Vials) by Application (2015-2020)
Table 44. United States Anti-Venom Sales Market Share by Application (2015-2020)
Table 45. Europe Anti-Venom Sales (K Vials) by Company (2015-2020)
Table 46. Europe Anti-Venom Sales Market Share by Company (2015-2020)
Table 47. Europe Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 48. Europe Anti-Venom Sales Market Share by Type (2015-2020)
Table 49. Europe Anti-Venom Sales (K Vials) by Application (2015-2020)
Table 50. Europe Anti-Venom Sales Market Share by Type (2015-2020)
Table 51. China Anti-Venom Sales (K Vials) by Company (2015-2020)
Table 52. China Anti-Venom Sales Market Share by Company (2015-2020)
Table 53. China Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 54. China Anti-Venom Sales Market Share by Type (2015-2020)
Table 55. China Anti-Venom Sales (K Vials) by Application (2015-2020)
Table 56. China Anti-Venom Sales Market Share by Application (2015-2020)
Table 57. Japan Anti-Venom Sales (K Vials) by Company (2015-2020)
Table 58. Japan Anti-Venom Sales Market Share by Company (2015-2020)
Table 59. Japan Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 60. Japan Anti-Venom Sales Market Share by Type (2015-2020)
Table 61. Japan Anti-Venom Sales (K Vials) by Application (2015-2020)
Table 62. Japan Anti-Venom Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Anti-Venom Sales (K Vials) by Company (2015-2020)
Table 64. Southeast Asia Anti-Venom Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 66. Southeast Asia Anti-Venom Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 68. Southeast Asia Anti-Venom Sales Market Share by Application (2015-2020)
Table 69. India Anti-Venom Sales (K Vials) by Company (2015-2020)
Table 70. India Anti-Venom Sales Market Share by Company (2015-2020)
Table 71. India Anti-Venom Sales (K Vials) by Type (2015-2020)
Table 72. India Anti-Venom Sales Market Share by Type (2015-2020)
Table 73. India Anti-Venom Sales (K Vials) by Application (2015-2020)
Table 74. India Anti-Venom Sales Market Share by Application (2015-2020)
Table 75. CSL Corporation Information
Table 76. CSL Description and Business Overview
Table 77. CSL Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 78. CSL Anti-Venom Product
Table 79. CSL Recent Development
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 83. Merck Anti-Venom Product
Table 84. Merck Recent Development
Table 85. BTG Corporation Information
Table 86. BTG Description and Business Overview
Table 87. BTG Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 88. BTG Anti-Venom Product
Table 89. BTG Recent Development
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 93. Pfizer Anti-Venom Product
Table 94. Pfizer Recent Development
Table 95. Haffkine Bio-Pharmaceutical Corporation Information
Table 96. Haffkine Bio-Pharmaceutical Description and Business Overview
Table 97. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 98. Haffkine Bio-Pharmaceutical Anti-Venom Product
Table 99. Haffkine Bio-Pharmaceutical Recent Development
Table 100. Rare Disease Therapeutics Corporation Information
Table 101. Rare Disease Therapeutics Description and Business Overview
Table 102. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 103. Rare Disease Therapeutics Anti-Venom Product
Table 104. Rare Disease Therapeutics Recent Development
Table 105. Flynn Pharma Corporation Information
Table 106. Flynn Pharma Description and Business Overview
Table 107. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 108. Flynn Pharma Anti-Venom Product
Table 109. Flynn Pharma Recent Development
Table 110. Vins Bioproducts Corporation Information
Table 111. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 112. Vins Bioproducts Description and Business Overview
Table 113. Vins Bioproducts Anti-Venom Product
Table 114. Vins Bioproducts Recent Development
Table 115. Bharat Serums and Vaccines Corporation Information
Table 116. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 117. Bharat Serums and Vaccines Description and Business Overview
Table 118. Bharat Serums and Vaccines Anti-Venom Product
Table 119. Bharat Serums and Vaccines Recent Development
Table 120. Serum Biotech Corporation Information
Table 121. Serum Biotech Description and Business Overview
Table 122. Serum Biotech Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 123. Serum Biotech Anti-Venom Product
Table 124. Serum Biotech Recent Development
Table 125. MicroPharm Corporation Information
Table 126. MicroPharm Description and Business Overview
Table 127. MicroPharm Anti-Venom Sales (K Vials), Revenue (Million USD), Price (USD/Vial) and Gross Margin (2015-2020)
Table 128. MicroPharm Anti-Venom Product
Table 129. MicroPharm Recent Development
Table 130. Production Base and Market Concentration Rate of Raw Material
Table 131. Key Suppliers of Raw Materials
Table 132. Anti-Venom Distributors List
Table 133. Anti-Venom Customers List
Table 134. Anti-Venom Market Key Trends
Table 135. Anti-Venom Key Opportunities and Drivers
Table 136. Anti-Venom Market Challenges
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti-Venom Product Picture
Figure 2. Global Anti-Venom Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Anti-Venom Market Share by Application in 2020 & 2026
Figure 6. Non-profit Institutions Examples
Figure 7. Hospitals and Clinic Examples
Figure 8. Global Anti-Venom Sales (K Vials) Growth Rate (2015-2026)
Figure 9. Global Anti-Venom Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Anti-Venom Price Trends Growth Rate (2015-2026) (USD/Vial)
Figure 11. Global Anti-Venom Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Anti-Venom Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Anti-Venom Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Anti-Venom Sales (K Vials) Growth Rate (2015-2026)
Figure 15. Europe Anti-Venom Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Anti-Venom Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Anti-Venom Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Anti-Venom Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Anti-Venom Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Anti-Venom Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Anti-Venom Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Anti-Venom Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Anti-Venom Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Anti-Venom Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Anti-Venom Players Market Share by Revenue in Anti-Venom 2015 & 2019
Figure 26. Anti-Venom Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Anti-Venom Revenue Share by Type (2015-2020)
Figure 28. Global Anti-Venom Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Anti-Venom Revenue Share by Application (2015-2020)
Figure 30. Global Anti-Venom Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Anti-Venom Sales Market Share by Type in 2019
Figure 32. United States Anti-Venom Sales Market Share by Type in 2019
Figure 33. Europe Anti-Venom Sales Market Share by Company in 2019
Figure 34. Europe Anti-Venom Sales Market Share by Type in 2019
Figure 35. Europe Anti-Venom Sales Market Share by Application in 2019
Figure 36. China Anti-Venom Sales Market Share by Company in 2019
Figure 37. China Anti-Venom Sales Market Share by Type in 2019
Figure 38. China Anti-Venom Sales Market Share by Application in 2019
Figure 39. Japan Anti-Venom Sales Market Share by Company in 2019
Figure 40. Japan Anti-Venom Sales Market Share by Type in 2019
Figure 41. Japan Anti-Venom Sales Market Share by Application in 2019
Figure 42. Southeast Asia Anti-Venom Sales Market Share by Company in 2019
Figure 43. Southeast Asia Anti-Venom Sales Market Share by Type in 2019
Figure 44. Southeast Asia Anti-Venom Sales Market Share by Application in 2019
Figure 45. India Anti-Venom Sales Market Share by Company in 2019
Figure 46. India Anti-Venom Sales Market Share by Type in 2019
Figure 47. India Anti-Venom Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Anti-Venom
Figure 50. Manufacturing Process Analysis of Anti-Venom
Figure 51. Anti-Venom Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
蒸散抑制剤の世界市場レポート2020 Market Analysis and Insights: Global Anti-Transpirant Market The global Anti-Transpirant market size is projected to reach US$ 404.2 million by 2026, from US$ 302.5 million in 2020, at a CAGR of 5.0% during 2021-2026. Global Anti-Transpirant Scope and Market Size The global Anti-Transpirant market i…- 空港アンチリターンゲートの世界市場レポート2020 Market Analysis and Insights: Global Anti-return Gate For Airports Market The global Anti-return Gate For Airports market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anti-return Gate For Airports Scope and Market Size The …
- 二輪車用アンチブレーキシステム（ABS）の世界市場レポート2020 An anti-lock braking system (ABS) is a safety anti-skid braking system used on aircraft and on land vehicles, such as cars, motorcycles, trucks and buses. ABS operates by preventing the wheels from locking up during braking, thereby maintaining tractive contact with the road surface. The introductio…
- アンチグレア製品の世界市場レポート2020 Market Analysis and Insights: Global Anti-Glare Products Market The global Anti-Glare Products market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anti-Glare Products Scope and Market Size The global Anti-Glare Products mar…
- アンチグレアフィルムの世界市場レポート2020 Market Analysis and Insights: Global Anti-Glare Film Market The global Anti-Glare Film market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Anti-Glare Film Scope and Market Size The global Anti-Glare Film market is segmented…